Literatur
- 1
Disse B, Reichl R, Speck G, Traunecker W, Rominger K L, Hammer R.
Ba 679 BR, a novel long-acting anticholinergic bronchodilator.
Life Sci.
1993;
52
537-544
- 2
Racké K, Matthiesen S.
The airway cholinergic system: Physiology and pharmacology.
Pulm Pharmacol Ther.
2004;
17
181-198
- 3
Racké K, Juergens U R, Matthiesen S.
Control by cholinergic mechanism.
Eur J Pharmacol (Special issue on respiratory pharmacology).
2005;
2006:
, epub ahead of print, DOI: 10.1016/j.ejphaar.2005.12.050
- 4
Disse B, Speck G A, Rominger K L, Witek T J, Hammer R.
Tiotropium (SpirivaTM): mechanistical considerations and clinical profile in obstructive
lung disease.
Life Sci.
1999;
64
457-464
- 5
Takahashi T, Belvisi M G, Patel H. et al .
Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission
in guinea pig and human airways.
Am J Respir Crit Care Med.
1994;
150
1640-1645
- 6 Spiriva® Fachinformation,. Hrsg. Boehringer Ingelheim und Pfizer
- 7
Türck D, Weber W, Sigmund R. et al .
Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different
degrees of renal impairment.
J Clin Pharmacol.
2004;
44
163-172
- 8
Vincken W, van Noord J A, Greefhorst A P. et al .
Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium.
Eur Respir J.
2002;
19
209-216
- 9
Koumis T, Samuel S.
Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic
obstructive pulmonary disease.
Clin Ther.
2005;
27
377-392
- 10
Olin J L.
Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease.
Am J Health Syst Pharm.
2005;
62
1263-1269
- 11
Kroegel C, Buhl R, Gillissen A, Petro W.
Asthma bronchiale versus chronisch-obstruktive Lungenkrankheit (COPD).
Dtsch Med Wochenschr.
2005;
130
812-818
- 12
Tashkin D, Kesten S.
Long-term treatment benefits with tiotropium in COPD patients with and without short-term
bronchodilator responses.
Chest.
2003;
123
1441-1449
- 13
Gosens R, Nelemans S A, Grootte Bromhaar M M, McKay S, Zaagsma J, Meurs H.
Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth
muscle.
Am J Respir Cell Mol Biol.
2003;
28
257-262
- 14
Gosens R, Bos I S, Zaagsma J, Meurs H.
Protective effects of tiotropium bromide in the progression of airway smooth muscle
remodeling.
Am J Respir Crit Care Med.
2005;
171
1096-1102
- 15
Hasani A, Toms N, Agnew J E, Sarno M, Harrison A J, Dilworth P.
The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients
with COPD.
Chest.
2004;
125
1726-1734
- 16
Littner M R, Ilowite J S, Tashkin D P. et al .
Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable
chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
1136-1142
Prof. Dr. med. Kurt Racké
Institut für Pharmakologie und Toxikologie, Rheinische Friedrich-Wilhelms-Universität
Bonn
Reuterstraße 2b
53113 Bonn
Email: racke.kurt@uni-bonn.de
